These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16970553)

  • 1. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.
    Salpeter SR; Buckley NS; Salpeter EE
    J Gen Intern Med; 2006 Oct; 21(10):1011-9. PubMed ID: 16970553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary management of chronic obstructive pulmonary disease: scientific review.
    Sin DD; McAlister FA; Man SF; Anthonisen NR
    JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.
    Salpeter SR; Buckley NS
    Clin Rev Allergy Immunol; 2006; 31(2-3):219-30. PubMed ID: 17085795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children.
    Plotnick LH; Ducharme FM
    Cochrane Database Syst Rev; 2000; (4):CD000060. PubMed ID: 11034671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.
    Salpeter SR
    Int J Chron Obstruct Pulmon Dis; 2007; 2(1):11-8. PubMed ID: 18044061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.
    Wilt TJ; Niewoehner D; MacDonald R; Kane RL
    Ann Intern Med; 2007 Nov; 147(9):639-53. PubMed ID: 17975187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials.
    Wedzicha JA; Buhl R; Lawrence D; Young D
    Respir Med; 2015 Jan; 109(1):105-11. PubMed ID: 25433954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Singh S; Loke YK; Furberg CD
    JAMA; 2008 Sep; 300(12):1439-50. PubMed ID: 18812535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of long-acting beta-agonists in stable COPD: a systematic review.
    Rodrigo GJ; Nannini LJ; Rodríguez-Roisin R
    Chest; 2008 May; 133(5):1079-87. PubMed ID: 18460518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medications for COPD: a review of effectiveness.
    Grimes GC; Manning JL; Patel P; Via RM
    Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergics in the treatment of chronic obstructive pulmonary disease.
    Beeh KM; Welte T; Buhl R
    Respiration; 2002; 69(4):372-9. PubMed ID: 12169757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
    Martinez FJ; Calverley PM; Goehring UM; Brose M; Fabbri LM; Rabe KF
    Lancet; 2015 Mar; 385(9971):857-66. PubMed ID: 25684586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis.
    Xia N; Wang H; Nie X
    PLoS One; 2015; 10(9):e0137904. PubMed ID: 26378450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
    N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.